Gyre Therapeutics, Inc. (GYRE)

Gyre Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	60.05	26.67	33.51	25.18	44.35	30.36
Short-Term Investments	-	-	-	-	2.5	48.99
Cash & Short-Term Investments	60.05	26.67	33.51	25.18	46.85	79.35
Cash Growth	139.31%	-20.41%	33.10%	-46.27%	-40.96%	3.24%
Accounts Receivable	25.88	19.59	15.16	17.14	1.82	3.31
Other Receivables	0.92	9.56	1.68	-	-	-
Total Trade Receivables	26.8	29.15	16.84	17.14	1.82	3.31
Inventory	8.85	6.34	4.28	6.12	-	-
Other Current Assets	2.87	2.63	2.59	1.22	2.81	6.84
Total Current Assets	98.58	64.79	57.22	49.65	51.48	89.51
Net Property, Plant & Equipment	23.61	23.88	23.76	18.38	3.71	2.27
Other Intangible Assets	4.85	0.27	0.21	0.3	-	-
Long-Term Investments	-	-	-	-	-	2.54
Other Long-Term Assets	32.35	36.47	11.91	16.43	0.47	0.53
Total Assets	159.38	125.41	116.54	84.75	55.66	94.85
Accounts Payable	0.56	0.11	0.36	0.12	6.42	5.93
Accrued Expenses	11.8	10.62	11.94	9.26	5.54	9.22
Current Portion of Leases	0.63	0.71	0.21	0.49	1.98	0.66
Unearned Revenue	0.06	0.06	0.04	0.15	0.23	1.98
Other Current Liabilities	2.87	8.02	7.51	2.22	-	-
Total Current Liabilities	15.91	19.52	20.05	12.24	14.17	17.8
Long-Term Leases	0.54	0.89	0.2	0.12	0.41	0.98
Other Long-Term Liabilities	5.52	6.6	17.82	0.17	-	-
Total Long-Term Liabilities	6.06	7.49	18.02	0.29	0.41	0.98
Total Liabilities	21.97	27	38.07	12.54	14.57	18.78
Common Stock	0.09	0.09	0.08	0.06	0.03	0.02
Additional Paid-in Capital	167.13	136.19	68.18	32.8	443.75	390.8
Accumulated Other Comprehensive Income	-1.7	-2.6	-1.64	-0.39	-	0.01
Retained Earnings	-63.61	-70.36	-82.44	10.06	-402.69	-314.76
Total Common Shareholders' Equity	101.92	63.32	-15.83	42.52	41.09	76.07
Minority Interest	35.5	35.08	94.3	29.7	-	-
Shareholders' Equity	137.42	98.4	13.95	72.22	41.09	76.07
Total Liabilities & Equity	159.38	125.41	116.54	84.75	55.66	94.85
Total Debt	1.17	1.6	0.41	0.61	2.39	1.64
Net Cash (Debt)	58.88	25.07	33.1	24.56	44.47	77.71
Net Cash Growth	134.85%	-24.25%	34.76%	-44.76%	-42.78%	3.53%
Net Cash Per Share	0.60	0.24	0.50	0.33	0.67	60.78
Book Value	101.92	63.32	-15.83	42.52	41.09	76.07
Book Value Per Share	1.03	0.62	-0.24	0.56	0.62	59.49
Tangible Book Value	97.07	63.05	-16.03	42.23	41.09	76.07
Tangible Book Value Per Share	0.98	0.62	-0.24	0.56	0.62	59.49

Updated Nov 7, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q